Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Regulation (EU) No 759/2010 of 24 August 2010 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance tildipirosin Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union . It shall apply from 24 October 2010.
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order: Pharmacologically active substance Marker residue Animal species MRL Target tissues Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification ‘Tildipirosin Tildipirosin Bovine, caprine 400 μg/kg Muscle Not for use in animals from which milk is produced for human consumption. The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 11 500 μg/kg. Provisional MRL shall expire on 1 January 2012. Macrolide’ 200 μg/kg Fat 2 000 μg/kg Liver 3 000 μg/kg Kidney Porcine 1 200 μg/kg Muscle The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 7 500 μg/kg. Provisional MRL shall expire on 1 January 2012. 800 μg/kg Skin and fat 5 000 μg/kg Liver 10 000 μg/kg Kidney
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.